Psychopharmacology and Psychiatry Updates
AUD Medications and Hepatic Safety
Donnerstag, 3. September 2026 · 10 min
Kapitelklicken springt direkt hin
Shownotes
In this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin Sevarino breaks down a practical algorithm for selecting between naltrexone, acamprosate, disulfiram, and other options, tailored to hepatic function, from early liver disease through decompensated cirrhosis.
Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D. Host: Richard Seeber, M.D.
• Learn more about our memberships here
• Earn 1.25 CME: Pharmacotherapy of Alcohol Use Disorder
• Alcohol Use Disorder Algorithm: Medication Selection Based on Liver Status